SCHEDULE 13D
This Amendment No. 22 (this “Amendment”) supplements the information set forth in the Schedule 13D filed by the Reporting Persons with the SEC, as amended from time to time (the “Schedule 13D”), relating to the common stock, par value $0.01 per share (“Common Stock”) of HF Sinclair Corporation, a Delaware corporation (the “Issuer”). All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D.
The information set forth in response to each separate Item below shall be deemed to be a response to all Items where such information is relevant. The Schedule 13D is hereby supplementally amended as follows:
Item 4. | Purpose of Transaction |
The information contained in Items 3 and 6 of the Schedule 13D is incorporated herein by reference.
On May 14, 2024, the Issuer entered into a Stock Purchase Agreement (the “Seventeenth Purchase Agreement”) with REH to repurchase 1,348,435 shares of the Issuer’s Common Stock, for $55.62 per share, for the aggregate purchase price of $74,999,955 in a privately negotiated transaction (the “Eighteenth Repurchase Transaction”). The Eighteenth Repurchase Transaction is expected to close on or about May 16, 2024, subject to customary closing conditions. The foregoing description of the Seventeenth Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Seventeenth Purchase Agreement, which is filed as Exhibit 10.18 hereto and is incorporated herein by reference.
As previously reported, the Reporting Persons have sold their Common Stock from time to time in both open market sales and sales to the Issuer. Subject to the terms of the Stockholders Agreement, dated August 2, 2021, by and between the Issuer, the Reporting Persons and certain other parties thereto (the “Stockholders Agreement”), the Reporting Persons expect to continue to engage in such sales (with a strong preference for sales to the Issuer), but the Reporting Persons may both acquire additional Common Stock or dispose of any or all of the Common Stock, in each case, depending upon an ongoing evaluation of the investment in the Common Stock, prevailing market conditions, other investment opportunities, other investment considerations and/or other factors. The Reporting Persons evaluate their investments in the Common Stock on a continual basis.
Additionally, while the Reporting Persons reserve the right to make sales from time to time, it is their intent as of the date of this Amendment to maintain such sufficient ownership of the Issuer’s Common Stock so the Reporting Persons retain the right to appoint at least one director to the Board of the Issuer pursuant to the Stockholders Agreement. The Reporting Persons may, at any time and from time to time, review or reconsider such position.
Item 5. | Interest in Securities of the Issuer. |
(a.) – (b.) The aggregate number and percentage of Common Stock beneficially owned by the Reporting Persons (on the basis of a total of 192,157,440 shares of Common Stock outstanding as of May 3, 2024, as reported in the Issuer’s Annual Report on Form 10-Q, filed with the SEC on May 8, 2024, less the Common Stock acquired by the Issuer pursuant to the Eighteenth Repurchase Transaction) are as follows:
| i. | Amount beneficially owned: 16,057,699 |
Percentage: 8.4%
| a. | Sole power to vote or to direct the vote: 0 |
| b. | Shared power to vote or to direct the vote: 16,057,699 |
| c. | Sole power to dispose or to direct the disposition of: 0 |
| d. | Shared power to dispose or to direct the disposition of: 16,057,699 |
4